OA
MNTA

OFI Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

OFI Advisors’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$40K Buy
2,461
+1,191
+94% +$24.4K ﹤0.01% 1605
2015
Q2 		$29K Sell
1,270
-628
-33% -$12.5K ﹤0.01% 1633
2015
Q1 		$29K Buy
1,898
+104
+6% +$1.35K ﹤0.01% 1647
2014
Q4 		$22K Sell
1,794
-28
-2% -$320 ﹤0.01% 1680
2014
Q3 		$21K Buy
1,822
+375
+26% +$4.28K ﹤0.01% 1659
2014
Q2 		$17K Buy
1,447
+427
+42% +$5.04K ﹤0.01% 1657
2014
Q1 		$12K Buy
1,020
+208
+26% +$3.52K ﹤0.01% 1673
2013
Q4 		$14K Buy
812
+155
+24% +$2.6K ﹤0.01% 1686
2013
Q3 		$9K Sell
657
-223
-25% -$3.41K ﹤0.01% 1698
2013
Q2 		$13K Buy
+880
New +$11.6K ﹤0.01% 1671

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

OFI Advisors's MNTA Position: Q3 2015 in Review

OFI Advisors increased its Momenta Pharmaceuticals, Inc. (MNTA) stake by 94% in Q3 2015, buying an estimated $24.4K and bringing the position to 2,461 shares worth $40K. The position accounts for ﹤0.01% of the portfolio, ranked #1605.

OFI Advisors first reported a position in MNTA in Q2 2013 and has held it in 10 quarters since. 156 funds tracked by Wall St. Rank hold MNTA as of Q3 2015.

  • OFI Advisors held 2,461 shares of Momenta Pharmaceuticals, Inc. worth $40K as of Q3 2015.
  • OFI Advisors bought 1,191 Momenta Pharmaceuticals, Inc. shares in Q3 2015, an estimated $24.4K.
  • Momenta Pharmaceuticals, Inc. made up ﹤0.01% of OFI Advisors's portfolio in Q3 2015, its #1605 holding.
  • OFI Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and has held it in 10 quarters since.
  • 156 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.